Idorsia
David Rossi is an accomplished professional with extensive experience in quality management and regulatory compliance within the pharmaceutical industry. Currently, Rossi serves as the Associate Director and Head of Global GxP Quality Management System & Services at Idorsia Pharmaceuticals Ltd since April 2022. Prior to this, Rossi worked at Novartis for a decade in various roles including Global GxP Training System Manager and QA Systems and Training Specialist. Additional experience includes leadership positions as Head of Quality Control at Rexam, Project Manager at SOGEI, and Quality Control Specialist at Wolff System, alongside entrepreneurship as the owner of UP - Communications. Rossi's career reflects a strong emphasis on quality assurance, training systems, and performance improvement.
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.